X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (303) 303
Publication (21) 21
Conference Proceeding (16) 16
Book Review (12) 12
Book Chapter (5) 5
Book / eBook (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (147) 147
index medicus (147) 147
cardiac & cardiovascular systems (120) 120
male (94) 94
female (92) 92
aged (73) 73
middle aged (72) 72
abridged index medicus (59) 59
treatment outcome (43) 43
acute coronary syndromes (41) 41
cardiovascular (38) 38
risk factors (35) 35
mortality (33) 33
anticoagulants (30) 30
anticoagulants - therapeutic use (30) 30
stroke (30) 30
cardiology (27) 27
medicine, general & internal (27) 27
atrial fibrillation (26) 26
internal medicine (26) 26
myocardial infarction (25) 25
care and treatment (24) 24
drug therapy (24) 24
heart attacks (24) 24
follow-up studies (23) 23
myocardial-infarction (23) 23
time factors (23) 23
clopidogrel (22) 22
heart attack (22) 22
prognosis (22) 22
angioplasty, balloon, coronary (21) 21
aspirin (21) 21
percutaneous coronary intervention (21) 21
acute coronary syndrome - drug therapy (20) 20
medical and health sciences (20) 20
medicin och hälsovetenskap (20) 20
myocardial infarction - drug therapy (20) 20
prospective studies (20) 20
coronary angiography (19) 19
fibrinolytic agents - therapeutic use (19) 19
risk assessment (19) 19
stents (19) 19
adult (18) 18
coronary heart disease (18) 18
heparin (18) 18
management (18) 18
anticoagulants - adverse effects (17) 17
medicine (17) 17
st-segment elevation (17) 17
aged, 80 and over (16) 16
diagnosis (16) 16
double-blind method (16) 16
guidelines (16) 16
hemorrhage - chemically induced (16) 16
myocardial infarction - mortality (16) 16
peripheral vascular disease (16) 16
recurrence (16) 16
platelet aggregation inhibitors - therapeutic use (15) 15
stent (15) 15
unstable angina (15) 15
acute coronary syndrome (14) 14
angioplasty (14) 14
cardiac patients (14) 14
electrocardiography (14) 14
enoxaparin (14) 14
health aspects (14) 14
hemorrhage - etiology (14) 14
practice guidelines as topic (14) 14
prevention (14) 14
therapy (14) 14
unfractionated heparin (14) 14
acute myocardial-infarction (13) 13
analysis (13) 13
hemorrhage (13) 13
heparin - therapeutic use (13) 13
myocardial infarction - therapy (13) 13
registries (13) 13
risk (13) 13
thrombolytic therapy (13) 13
hematology (12) 12
medicin (12) 12
myocardial infarction - diagnosis (12) 12
polysaccharides - therapeutic use (12) 12
survival analysis (12) 12
task-force (12) 12
acute coronary syndrome - mortality (11) 11
acute coronary syndrome - therapy (11) 11
acute disease (11) 11
coronary artery bypass (11) 11
coronary disease - therapy (11) 11
fondaparinux (11) 11
stroke - prevention & control (11) 11
trial (11) 11
angina pectoris (10) 10
bleeding (10) 10
cardiology and cardiovascular medicine (10) 10
clinical-outcomes (10) 10
dosage and administration (10) 10
drug therapy, combination (10) 10
enoxaparin - therapeutic use (10) 10
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (271) 271
French (17) 17
Spanish (9) 9
Italian (4) 4
Portuguese (4) 4
Chinese (2) 2
Polish (2) 2
Czech (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Heart Journal, ISSN 0195-668X, 10/2014, Volume 35, Issue 37, pp. 2507 - 2509
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2014, Volume 35, Issue 37, pp. 2507 - 2509
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2010, Volume 363, Issue 10, pp. 930 - 942
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2012, Volume 366, Issue 1, pp. 9 - 19
In patients with acute coronary syndromes, low doses of rivaroxaban were effective in reducing the primary end point of death from cardiovascular causes,... 
ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | PLACEBO | EVENTS | MYOCARDIAL-INFARCTION | SAFETY | DOUBLE-BLIND | THROMBOPROPHYLAXIS | APIXABAN | FACTOR XA INHIBITOR | ANTIPLATELET THERAPY | Thiophenes - therapeutic use | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hemorrhage - mortality | Male | Secondary Prevention | Thiophenes - administration & dosage | Incidence | Rivaroxaban | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Drug Administration Schedule | Morpholines - administration & dosage | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Acute Coronary Syndrome - drug therapy | Intracranial Hemorrhages - chemically induced | Aged | Hemorrhage - chemically induced | Drugs | Dose-response relationship (Biochemistry) | Dosage and administration | Product/Service Evaluations | Drug therapy | Coronary heart disease | Myocardial infarction | Cerebral infarction | Anticoagulants | Heart attacks | Arteriosclerosis | Cardiovascular disease | Death | Angina pectoris | Hemorrhage | Thrombosis | Bleeding | Index Medicus | Abridged Index Medicus
Journal Article
Revista Espanola de Cardiologia, ISSN 1885-5857, 03/2017, Volume 70, Issue 3, p. 140
Journal Article
Journal Article